Our investigation unveiled a significant decline in the protein levels of ERK2, but not ERK1, following SENP2 knockdown in the xenograft mouse model (Fig. 3A), suggesting that SENP2 specifically regulated ERK2 but not ERK1 in breast cancer. Here, MAPK3 is linked to breast cancer.